Hopes for obesity / diabetes treatment

Israel’s Prolor Biotech announced positive results in a pre-clinical trial of MOD-6030, its long-acting obesity/Type II diabetes drug. In the laboratory, the drug reduced blood glucose levels, increased insulin sensitivity, and reduced cholesterol levels compared to a placebo.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *